Association Between Interleukin-10 Gene (-1082g/A) Polymorphism and Type 2 Diabetes, Diabetes-Related Traits, and Microvascular Complications in the Croatian Population

Overview

Journal Acta Clin Croat

Specialty General Medicine

Date 2018 Sep 27

PMID 30256013

Citations 8

Authors

Silvija Canecki-Varzic

Ivana Prpic-Krizevac

Silvio Mihaljevic

Ines Bilic-Curcic

Tamara Alkhamis

Jasenka Wagner

Ivana Skrlec

Jerko Barbic

Affiliations

Soon will be listed here.

Abstract

Interleukin (IL)-10 is an anti-inflammatory cytokine, and a decrease in its secretion is associated with obesity, metabolic syndrome and type 2 diabetes. However, it has not been established whether the intensity of the immune response during diabetes-associated chronic inflammation affects the development and/or progression of type 2 diabetes and its microvascular complications. The aim of this study was to investigate the role of single nucleotide polymorphism (SNP)-1082G/A for IL-10 gene in development of diabetes type 2 and its complications. DNA was extracted from blood cells of 240 overweight/obese subjects for IL-10 genotyping. Based on the presence of diabetes type 2, patients were divided in two groups: experimental group of 144 patients with diabetes type 2 and control group of 96 age- and gender-matched subjects without diabetes. Compared to control group, diabetic group had higher levels of leukocytes (p=0.012), fibrinogen (p=0.049) and plasminogen activator inhibitor-1 (PAI-1) (p=0.009), and lower levels of albumin (p=0.001). There were no differences in the frequency of SNP-1082G/A for IL-10 gene between the two groups (p=0.654). When considering diabetes related traits in all subjects in relation to specific genotype, a group with homozygous (AA) genotype had higher values of the mean fasting glucose (p<0.000001), HbA1c (p<0.000001) and HOMA-IR (p=0.003632), while the mean HOMA-B value (p=0.000178) was lower when compared to the groups with GG and GA genotypes. There was no difference in devel-opment of diabetic nephropathy, retinopathy and polyneuropathy between the IL-10 polymorphism genotypes. In conclusion, obese diabetes type 2 patients had an increased inflammation activity com-pared to obese non-diabetic individuals. There was no association of the investigated polymorphisms and development of type 2 diabetes and its microvascular complications. However, diabetes related traits clearly depended on the presence of specific IL-10 genotype.

Citing Articles

Bioengineering Skin Substitutes for Wound Management-Perspectives and Challenges.

Kondej K, Zawrzykraj M, Czerwiec K, Deptula M, Tyminska A, Pikula M Int J Mol Sci. 2024; 25(7).

PMID: 38612513 PMC: 11011330. DOI: 10.3390/ijms25073702.

SERUM URIC ACID TO HDL CHOLESTEROL RATIO IS ASSOCIATED WITH DIABETIC CONTROL IN NEW ONSET TYPE 2 DIABETIC POPULATION.

Kosekli M, Aktas G Acta Clin Croat. 2024; 62(2):277-282.

PMID: 38549603 PMC: 10969632. DOI: 10.20471/acc.2023.62.02.04.

Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes.

Nirenjen S, Narayanan J, Tamilanban T, Subramaniyan V, Chitra V, Fuloria N Front Immunol. 2023; 14:1216321.

PMID: 37575261 PMC: 10414543. DOI: 10.3389/fimmu.2023.1216321.

The role of maternal DNA methylation in pregnancies complicated by gestational diabetes.

Dias S, Willmer T, Adam S, Pheiffer C Front Clin Diabetes Healthc. 2023; 3:982665.

PMID: 36992770 PMC: 10012132. DOI: 10.3389/fcdhc.2022.982665.

The effect of gene polymorphism on obesity parameters in highly physically active young men.

Maculewicz E, Mastalerz A, Antkowiak B, Antkowiak O, Garbacz A, Szarska E Biol Sport. 2022; 39(4):1117-1125.

PMID: 36247965 PMC: 9536378. DOI: 10.5114/biolsport.2023.118336.

References

Duncan B, Schmidt M, Offenbacher S, Wu K, Savage P, Heiss G . Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 1999; 22(5):767-72. DOI: 10.2337/diacare.22.5.767. View

Schmidt M, Duncan B, Sharrett A, Lindberg G, Savage P, Offenbacher S . Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999; 353(9165):1649-52. DOI: 10.1016/s0140-6736(99)01046-6. View

Tagore A, Gonsalkorale W, Pravica V, Hajeer A, McMahon R, Whorwell P . Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens. 1999; 54(4):386-90. DOI: 10.1034/j.1399-0039.1999.540408.x. View

van Exel E, Gussekloo J, de Craen A, Frolich M, Bootsma-van der Wiel A, Westendorp R . Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study. Diabetes. 2002; 51(4):1088-92. DOI: 10.2337/diabetes.51.4.1088. View

Festa A, DAgostino Jr R, Tracy R, Haffner S . Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2002; 51(4):1131-7. DOI: 10.2337/diabetes.51.4.1131. View

Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaross W . Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism. 2002; 51(6):743-9. DOI: 10.1053/meta.2002.32804. View

Muller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B . Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia. 2002; 45(6):805-12. DOI: 10.1007/s00125-002-0829-2. View

Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S . Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet. 2002; 11(21):2607-14. DOI: 10.1093/hmg/11.21.2607. View

Donath M, Storling J, Maedler K, Mandrup-Poulsen T . Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med (Berl). 2003; 81(8):455-70. DOI: 10.1007/s00109-003-0450-y. View

10.

Genuth S, Alberti K, Bennett P, Buse J, DeFronzo R, Kahn R . Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26(11):3160-7. DOI: 10.2337/diacare.26.11.3160. View

11.

Otero M, Lago R, Lago F, Casanueva F, Dieguez C, Gomez-Reino J . Leptin, from fat to inflammation: old questions and new insights. FEBS Lett. 2005; 579(2):295-301. DOI: 10.1016/j.febslet.2004.11.024. View

12.

Karelis A, Faraj M, Bastard J, St-Pierre D, Brochu M, Prudhomme D . The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005; 90(7):4145-50. DOI: 10.1210/jc.2005-0482. View

13.

Scarpelli D, Cardellini M, Andreozzi F, Laratta E, Letizia Hribal M, Marini M . Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. Diabetes. 2006; 55(5):1529-33. DOI: 10.2337/db06-0047. View

14.

Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H . Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006; 29(6):1357-62. DOI: 10.2337/dc05-1801. View

15.

Shoelson S, Lee J, Goldfine A . Inflammation and insulin resistance. J Clin Invest. 2006; 116(7):1793-801. PMC: 1483173. DOI: 10.1172/JCI29069. View

16.

Sako Y, Grill V . A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology. 1990; 127(4):1580-9. DOI: 10.1210/endo-127-4-1580. View

17.

Snijder M, Heine R, Seidell J, Bouter L, Stehouwer C, Nijpels G . Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. Diabetes Care. 2006; 29(11):2498-503. DOI: 10.2337/dc06-0952. View

18.

Menzaghi C, Trischitta V, Doria A . Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes. 2007; 56(5):1198-209. DOI: 10.2337/db06-0506. View

19.

Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, Arikan S . The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults?. J Endocrinol Invest. 2007; 30(3):210-4. DOI: 10.1007/BF03347427. View

20.

Lee J, Lee W, Kwon O, Kim J, Kwon O, Kim K . Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy. Ann Clin Lab Sci. 2008; 38(4):361-7. View